Large-scale ex Vivo Expansion and Characterization of Synovial Membrane MSC (SM-MSC) and Infrapatellar Fat Pad MSC (IF-MSC) for Clinical Application
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Knee Injuries
- Sponsor
- EMO Biomedicine Corporation
- Enrollment
- 6
- Locations
- 1
- Primary Endpoint
- Compare MSCs from synovial membrane and infrapatellar fat pad
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
According to many researches, mesenchymal stem cells (MSC) isolated from synovial membrane and infrapatellar fat pad have higher ex vivo proliferation capacity, multipotency and ability to undergo chondrogenesis.
Based on this concept, the investigators plan to get two removed tissues (synovial membrane and infrapatellar fat pad) from patients who have an operation of TKR (Total Knee Replacement). The investigators are going to isolate and expand MSC from these two tissues respectively, and then compare their characterization and potential for clinical application. In the other hand, the investigators plan to build techniques and procedures which comply with "Good Tissue Practices (GTP)".
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient who have an total knee replacement surgery
Exclusion Criteria
- •Patient who don't sign the agreement
Outcomes
Primary Outcomes
Compare MSCs from synovial membrane and infrapatellar fat pad
Time Frame: 2 months
Comparison items include doubling time, phenotype, chondrogenesis and biological activity.